logo
Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients
New evidence on the potential role of the metabolic syndrome as a risk factor for venous thromboembolism
Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome
Metabolic syndrome and risk of venous thromboembolism
Validation of a diagnostic approach to exclude recurrent venous thromboembolism
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
The costs of heparin-induced thrombocytopenia
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B
Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy
Rituximab and immune tolerance in severe hemophilia A
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy
Mutagenesis studies toward understanding the intracellular signaling mechanism of antithrombin
Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A
Discordant fibrin formation in hemophilia
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I
von Willebrand factor is a major determinant of ADAMTS-13 decrease during mouse sepsis induced by cecum ligation and puncture
Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock
Optimization of a murine immunization model for study of PF4/heparin antibodies
Abnormal platelet function in C3-deficient mice
Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro
Definition of post-thrombotic syndrome of the leg for use in clinical investigations
Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome
Is the preoperative administration of enoxaparin 40 mg necessary to optimally prevent the occurrence of venous thromboembolism after hip surgery? A subanalysis of two pooled randomized trials
Risk of myocardial infarction persisting after discontinuation of non-steroidal anti-inflammatory drugs in the general population
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease
The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome
CD9 negatively regulates integrin αIIbβ3 activation and could thus prevent excessive platelet recruitment at sites of vascular injury
High thrombin-activatable fibrinolysis inhibitor levels may protect against recurrent fetal loss
More on
Birger Blombäck (May 7, 1926 – October 2, 2008)
Join ISTH